Table 2 Clinical and immunological characteristics across DM-SSP intervention timepoints (n = 8)
| Â | Baseline | Post-intervention |
|---|---|---|
Hemoglobin A1c, mean % (SD) | 8.9 (1.3) | 8.7 (2.4) |
Weight, lbs, mean (SD) | 224.9 (37.0) | 220.5 (35.9)* |
Body mass index, kg/m2, mean (SD) | 36.2 (5.2) | 35.5 (4.9)* |
Systolic blood pressure, mmHg, mean (SD) | 121.9 (10.2) | 132.3 (24.4) |
Diastolic blood pressure, mmHg, mean (SD) | 76.2 (7.5) | 84.9 (10.0) |
Lipids, mg/dL, mean (SD) | ||
 Total cholesterol | 196.8 (49.0) | 176.9 (33.7) |
 High-density lipoprotein cholesterol | 37.7 (7.0) | 37.3 (9.2) |
 Low-density lipoprotein cholesterol | 85.3 (23.9) | 87.0 (23.8) |
 Triglycerides | 413.4 (258.0) | 405.9 (199.6) |
 Problem areas in diabetes score, mean (SD) | 46.7 (20.7) | 33.4 (26.8) |
 Diabetes care profile, mean (SD) | 2.7 (0.8) | 4.0 (1.0)** |
 Summary of diabetes self-care activities, mean (SD) | 14.3 (4.1) | 18.1 (5.1) |